In Vitro-In Vivo Correlations Observed With Indacaterol-Based Formulations Delivered with the Breezhaler®. 2015

Jeffry G Weers, and Andrew R Clark, and Nagaraja Rao, and Keith Ung, and Alfred Haynes, and Sanjeev K Khindri, and Sheryl A Perry, and Surendra Machineni, and Paul Colthorpe
1 Novartis Pharmaceuticals Corporation , San Carlos, California, United States .

BACKGROUND Establishing robust in vitro-in vivo correlations (IVIVC) between aerosol performance, pharmacokinetics, and clinical efficacy is critical in developing bioequivalent drug-device combination products. Recent studies have demonstrated that realistic throat models tested under realistic test conditions may provide good IVIVC with respect to total lung deposition. METHODS The Alberta idealized throat (AIT) model was utilized with mean peak inspiratory flow rates determined from patient breathing studies. Various formulations of indacaterol (e.g., lactose blends, fixed dose combinations, engineered PulmoSphere™ particles) were tested in the AIT model and in clinical pharmacokinetic studies. RESULTS Good IVIVC were observed with respect to total lung deposition, systemic delivery, and the contribution of oral absorption to systemic delivery, with percentage differences from the mean in vivo measurements <15%, with most comparisons <5%. CONCLUSIONS Anatomical throat models represent an exciting tool to aid in formulation development of pharmaceutical aerosols.

UI MeSH Term Description Entries
D007189 Indans Aryl CYCLOPENTANES that are a reduced (protonated) form of INDENES. Indanones
D007785 Lactose A disaccharide of GLUCOSE and GALACTOSE in human and cow milk. It is used in pharmacy for tablets, in medicine as a nutrient, and in industry. Anhydrous Lactose,Lactose, Anhydrous
D008953 Models, Anatomic Three-dimensional representation to show anatomic structures. Models may be used in place of intact animals or organisms for teaching, practice, and study. Anatomic Models,Models, Surgical,Moulages,Models, Anatomical,Anatomic Model,Anatomical Model,Anatomical Models,Model, Anatomic,Model, Anatomical,Model, Surgical,Moulage,Surgical Model,Surgical Models
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D010316 Particle Size Relating to the size of solids. Particle Sizes,Size, Particle,Sizes, Particle
D010614 Pharynx A funnel-shaped fibromuscular tube that conducts food to the ESOPHAGUS, and air to the LARYNX and LUNGS. It is located posterior to the NASAL CAVITY; ORAL CAVITY; and LARYNX, and extends from the SKULL BASE to the inferior border of the CRICOID CARTILAGE anteriorly and to the inferior border of the C6 vertebra posteriorly. It is divided into the NASOPHARYNX; OROPHARYNX; and HYPOPHARYNX (laryngopharynx). Throat,Pharynxs,Throats
D011208 Powders Substances made up of an aggregation of small particles, as that obtained by grinding or trituration of a solid drug. In pharmacy it is a form in which substances are administered. (From Dorland, 28th ed) Powder
D001993 Bronchodilator Agents Agents that cause an increase in the expansion of a bronchus or bronchial tubes. Bronchial-Dilating Agents,Bronchodilator,Bronchodilator Agent,Broncholytic Agent,Bronchodilator Effect,Bronchodilator Effects,Bronchodilators,Broncholytic Agents,Broncholytic Effect,Broncholytic Effects,Agent, Bronchodilator,Agent, Broncholytic,Agents, Bronchial-Dilating,Agents, Bronchodilator,Agents, Broncholytic,Bronchial Dilating Agents,Effect, Bronchodilator,Effect, Broncholytic,Effects, Bronchodilator,Effects, Broncholytic
D002626 Chemistry, Pharmaceutical Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use. Medicinal Chemistry,Chemistry, Pharmaceutic,Pharmaceutic Chemistry,Pharmaceutical Chemistry,Chemistry, Medicinal
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier

Related Publications

Jeffry G Weers, and Andrew R Clark, and Nagaraja Rao, and Keith Ung, and Alfred Haynes, and Sanjeev K Khindri, and Sheryl A Perry, and Surendra Machineni, and Paul Colthorpe
October 2021, Revue medicale de Liege,
Jeffry G Weers, and Andrew R Clark, and Nagaraja Rao, and Keith Ung, and Alfred Haynes, and Sanjeev K Khindri, and Sheryl A Perry, and Surendra Machineni, and Paul Colthorpe
November 1987, Methods and findings in experimental and clinical pharmacology,
Jeffry G Weers, and Andrew R Clark, and Nagaraja Rao, and Keith Ung, and Alfred Haynes, and Sanjeev K Khindri, and Sheryl A Perry, and Surendra Machineni, and Paul Colthorpe
April 1996, Biopharmaceutics & drug disposition,
Jeffry G Weers, and Andrew R Clark, and Nagaraja Rao, and Keith Ung, and Alfred Haynes, and Sanjeev K Khindri, and Sheryl A Perry, and Surendra Machineni, and Paul Colthorpe
July 2021, European journal of drug metabolism and pharmacokinetics,
Jeffry G Weers, and Andrew R Clark, and Nagaraja Rao, and Keith Ung, and Alfred Haynes, and Sanjeev K Khindri, and Sheryl A Perry, and Surendra Machineni, and Paul Colthorpe
January 1996, European journal of drug metabolism and pharmacokinetics,
Jeffry G Weers, and Andrew R Clark, and Nagaraja Rao, and Keith Ung, and Alfred Haynes, and Sanjeev K Khindri, and Sheryl A Perry, and Surendra Machineni, and Paul Colthorpe
September 2011, Revue medicale de Liege,
Jeffry G Weers, and Andrew R Clark, and Nagaraja Rao, and Keith Ung, and Alfred Haynes, and Sanjeev K Khindri, and Sheryl A Perry, and Surendra Machineni, and Paul Colthorpe
January 2018, PloS one,
Jeffry G Weers, and Andrew R Clark, and Nagaraja Rao, and Keith Ung, and Alfred Haynes, and Sanjeev K Khindri, and Sheryl A Perry, and Surendra Machineni, and Paul Colthorpe
May 2021, Clinical drug investigation,
Jeffry G Weers, and Andrew R Clark, and Nagaraja Rao, and Keith Ung, and Alfred Haynes, and Sanjeev K Khindri, and Sheryl A Perry, and Surendra Machineni, and Paul Colthorpe
July 2019, Pharmaceutics,
Jeffry G Weers, and Andrew R Clark, and Nagaraja Rao, and Keith Ung, and Alfred Haynes, and Sanjeev K Khindri, and Sheryl A Perry, and Surendra Machineni, and Paul Colthorpe
March 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V,
Copied contents to your clipboard!